1-(邻甲苯基)哌嗪，CAS 登记号 39512-51-1，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 1-(邻甲苯基)哌嗪 的 CAS 号：39512-51-1，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
1-(o-Tolyl)piperazine · CAS 39512-51-1 · C11H16N2. UNII 6P26KQQ7V5. LogP: 2.14.
| CAS Registry Number | 39512-51-1 |
|---|---|
| PubChem CID | 91965 |
| Molecular formula | C11H16N2 |
| IUPAC name | 1-(2-methylphenyl)piperazine |
| UNII (FDA) | 6P26KQQ7V5 |
| Molecular Weight | 176.26 |
|---|---|
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Exact Mass | 176.131348519 |
| Monoisotopic Mass | 176.131348519 |
| Topological Polar Surface Area | 15.3 |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| LogP | 2.14 |
|---|
| Reported hazard statements | H311 (40%), H314 (86.7%), H318 (53.3%), H350 (46.7%) |
|---|
H311 (40%): Toxic in contact with skin [Danger Acute toxicity, dermal]
H314 (86.7%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]
1-(2-Methylphenyl)piperazine; 39512-51-1; 1-(o-Tolyl)piperazine; Piperazine, 1-(2-methylphenyl)-; 4-(2-Methylphenyl)piperazine; ortho-Methylphenylpiperazine; 2-Mepp; 6P26KQQ7V5; EINECS 254-481-9; O-METHYLPHENYLPIPERAZINE; DTXSID00192651; RefChem:474014; DTXCID40115142; 254-481-9; 1-o-tolylpiperazine; 1-(2-Methylphenyl)-piperazine
CAS 39512-51-1; molecular formula C11H16N2; molecular weight — g/mol.
1-(2-Methylphenyl)piperazine, 39512-51-1, 1-(o-Tolyl)piperazine, Piperazine, 1-(2-methylphenyl)-, 4-(2-Methylphenyl)piperazine, ortho-Methylphenylpiperazine.
Hazard statements reported: H311, H314, H318, H350.
LogP: 2.14.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.